PuREC Co.Ltd. is a bio-venture company founded in 2016 with the goal of utilizing ultra-high-purity human bone marrow-derived stem cells "REC®︎" to address various intractable diseases. The company's slogan, "Ultra-pure human bone marrow derived mesenchymal stem cell “REC”", reflects its focus on innovation in the health care and pharmaceutical industries. Based in Japan, PuREC Co.Ltd. secured a significant ¥580.00M Series A investment on 19 June 2019, with backing from notable investors including Gogin Capital, Fujifilm, REVIC, and Fast Track Initiative, Inc. As a content writer and startup analyst, it's important to highlight the innovative approach of PuREC Co.Ltd. in utilizing advanced stem cell technology for therapeutic applications. The company's successful Series A funding round, led by prominent investors, demonstrates strong confidence in its potential for addressing unmet medical needs. PuREC's focus on intractable diseases and its cutting-edge technology position it well for future growth and impact in the healthcare sector.
No recent news or press coverage available for PuREC Co.Ltd..